BofA analyst Brad Sills lowered the firm’s price target on Bill to $140 from $150 and keeps a Buy rating on the shares. Bill reported healthy Q4 results, with the FY24 outlook again muted by a conservative assumption in a still challenging macro, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BILL: